|
VOLUME 32: SUPPLEMENT 72 JANUARY 2005
Frontiers in Inflammatory Joint Diseases Conference
Toronto, Canada
May 7-9, 2004
Introduction
 
R.D. Inman, H.S. El-Gabalawy ......... 1
Common Denominators of Inflammatory Joint Diseases
H. S. El-Gabalawy ......... 3
Animal Models of Arthritis. What Have We Learned?
W.B. van den Berg ......... 7
Genetic Studies in the Rheumatic Diseases: Present Status and Implications for the Future
J.D. Reveille ......... 10
Rheumatoid Arthritis Initial Therapy: Unanswered Questions
J. O'Dell ........ 14
Gene Therapy: What Have We Accomplished and Where Do We Go from Here?
C.H. Evans ......... 17
What Else Can I Do But Take Drugs? The Future of Research in Nonpharmacological Treatment in Early Inflammatory Arthritis
L.C. Li ......... 21
Analyzing Synovial Tissue Samples. What Can We Learn About Early Rheumatoid Arthritis, the Heterogeneity of the Disease, and the Effects of Treatment?
P.P. Tak ......... 25
Clinical Research and the New Public Partnership - A View from the South
D.R. Lappin ......... 27
Longitudinal Cohort Studies
D.D. Gladman, V.T. Farewell ......... 30
Treating Children with Arthritis: Towards an Evidence-Based Culture
B.M. Feldman .........33
Is Early Intervention Worth It?
E. Yelin ......... 36
Arthritis in Canada: What Do We Know and What Should We Know?
E.M. Badley ......... 39
Arthritis and Employment Research: Where Are We? Where Do We Need to Go?
D. Lacaille ......... 42
The Anti-Tumor Necrosis Factor Agents Are a Major Advance in the Treatment of Rheumatoid Arthritis
B. Haraoui ......... 46
Assessing the Safety of Biologic Therapies in Rheumatoid Arthritis: The Challenges of Study Design
K.L. Hyrich ......... 48
Cost-Effectiveness Estimates Reported for Tumor Necrosis Factor Blocking Agents in Rheumatoid Arthritis Refractory to Methotrexate - A Brief Summary
A. Maetzel ......... 51
Integrating Biologic Therapy into the Comprehensive Care of Patients with Rheumatoid Arthritis
P.E. Lipsky ......... 54
Setting Research Priorities for Arthritis: The Environmental Perspective
J.W. Frank ......... 58
Summary and Conclusion
R.D. Inman, H.S. El-Gabalawy ......... 62
Acknowledgments ......... 64
| 
